Surmodics (SRDX) Competitors $28.34 -0.10 (-0.35%) Closing price 04:00 PM EasternExtended Trading$28.33 -0.01 (-0.04%) As of 04:05 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock SRDX vs. ATRC, IART, ATEC, OFIX, ANGO, ARAY, RMTI, RSLS, ABT, and ISRGShould you be buying Surmodics stock or one of its competitors? The main competitors of Surmodics include AtriCure (ATRC), Integra LifeSciences (IART), Alphatec (ATEC), Orthofix Medical (OFIX), AngioDynamics (ANGO), Accuray (ARAY), Rockwell Medical (RMTI), ReShape Lifesciences (RSLS), Abbott Laboratories (ABT), and Intuitive Surgical (ISRG). These companies are all part of the "health care equipment" industry. Surmodics vs. AtriCure Integra LifeSciences Alphatec Orthofix Medical AngioDynamics Accuray Rockwell Medical ReShape Lifesciences Abbott Laboratories Intuitive Surgical Surmodics (NASDAQ:SRDX) and AtriCure (NASDAQ:ATRC) are both small-cap medical companies, but which is the superior business? We will compare the two businesses based on the strength of their community ranking, analyst recommendations, dividends, media sentiment, risk, institutional ownership, profitability, valuation and earnings. Does the MarketBeat Community prefer SRDX or ATRC? AtriCure received 236 more outperform votes than Surmodics when rated by MarketBeat users. Likewise, 69.66% of users gave AtriCure an outperform vote while only 62.36% of users gave Surmodics an outperform vote. CompanyUnderperformOutperformSurmodicsOutperform Votes33862.36% Underperform Votes20437.64% AtriCureOutperform Votes57469.66% Underperform Votes25030.34% Which has higher valuation and earnings, SRDX or ATRC? Surmodics has higher earnings, but lower revenue than AtriCure. AtriCure is trading at a lower price-to-earnings ratio than Surmodics, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioSurmodics$125.45M3.23-$11.54M-$1.01-28.06AtriCure$465.31M3.40-$44.70M-$0.95-34.06 Do analysts rate SRDX or ATRC? Surmodics currently has a consensus price target of $50.00, indicating a potential upside of 76.43%. AtriCure has a consensus price target of $49.44, indicating a potential upside of 52.79%. Given Surmodics' higher possible upside, equities research analysts plainly believe Surmodics is more favorable than AtriCure.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Surmodics 0 Sell rating(s) 3 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 2.25AtriCure 0 Sell rating(s) 0 Hold rating(s) 9 Buy rating(s) 0 Strong Buy rating(s) 3.00 Does the media favor SRDX or ATRC? In the previous week, AtriCure had 8 more articles in the media than Surmodics. MarketBeat recorded 11 mentions for AtriCure and 3 mentions for Surmodics. Surmodics' average media sentiment score of 1.73 beat AtriCure's score of 1.10 indicating that Surmodics is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Surmodics 2 Very Positive mention(s) 0 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Very Positive AtriCure 7 Very Positive mention(s) 0 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Which has more volatility and risk, SRDX or ATRC? Surmodics has a beta of 1.3, suggesting that its stock price is 30% more volatile than the S&P 500. Comparatively, AtriCure has a beta of 1.65, suggesting that its stock price is 65% more volatile than the S&P 500. Is SRDX or ATRC more profitable? AtriCure has a net margin of -9.61% compared to Surmodics' net margin of -11.48%. Surmodics' return on equity of -4.39% beat AtriCure's return on equity.Company Net Margins Return on Equity Return on Assets Surmodics-11.48% -4.39% -2.95% AtriCure -9.61%-6.80%-5.19% Do institutionals and insiders believe in SRDX or ATRC? 96.6% of Surmodics shares are held by institutional investors. Comparatively, 99.1% of AtriCure shares are held by institutional investors. 8.9% of Surmodics shares are held by company insiders. Comparatively, 3.2% of AtriCure shares are held by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company will outperform the market over the long term. SummaryAtriCure beats Surmodics on 11 of the 18 factors compared between the two stocks. Remove Ads Get Surmodics News Delivered to You Automatically Sign up to receive the latest news and ratings for SRDX and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart SRDX vs. The Competition Export to ExcelMetricSurmodicsSurgical & medical instruments IndustryMedical SectorNASDAQ ExchangeMarket Cap$405.15M$4.07B$5.33B$7.57BDividend YieldN/A39.50%5.11%4.32%P/E Ratio-28.0627.6321.7317.81Price / Sales3.2350.20379.2094.61Price / Cash111.1251.0838.1534.64Price / Book3.625.826.464.00Net Income-$11.54M$67.09M$3.20B$247.23M7 Day Performance3.58%5.64%6.54%7.26%1 Month Performance0.14%-3.20%-8.55%-6.26%1 Year Performance7.27%14.87%10.33%-0.18% Surmodics Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)SRDXSurmodics4.1704 of 5 stars$28.34-0.4%$50.00+76.4%+5.3%$405.15M$125.45M-28.06450Positive NewsATRCAtriCure3.9093 of 5 stars$31.59+0.9%$49.44+56.5%+35.4%$1.54B$465.31M-33.251,300Short Interest ↓News CoveragePositive NewsGap DownIARTIntegra LifeSciences4.2664 of 5 stars$19.58+0.1%$23.00+17.5%-49.0%$1.51B$1.61B-217.533,720Short Interest ↓ATECAlphatec3.941 of 5 stars$10.01-2.2%$17.67+76.5%-23.5%$1.44B$611.56M-7.82700Analyst ForecastOptions VolumeNews CoverageHigh Trading VolumeOFIXOrthofix Medical2.9048 of 5 stars$14.36-1.5%$23.33+62.5%+1.2%$560.36M$799.49M-4.591,090Gap DownANGOAngioDynamics4.2359 of 5 stars$9.31+2.2%$14.00+50.4%+53.7%$376.74M$283.32M-1.65760Positive NewsARAYAccuray2.921 of 5 stars$1.57flatN/A-33.8%$161.45M$453.14M-31.401,040News CoverageGap DownRMTIRockwell Medical4.1596 of 5 stars$0.97-2.9%$4.00+311.9%-34.7%$33.07M$101.49M-19.42300News CoverageNegative NewsGap DownRSLSReShape Lifesciences0.4377 of 5 stars$0.43-5.8%N/A-95.9%$1.43M$8.18M-0.0350Short Interest ↑High Trading VolumeABTAbbott Laboratories4.8727 of 5 stars$124.71+0.2%$137.94+10.6%+17.1%$216.28B$41.95B16.30115,000Upcoming EarningsOptions VolumePositive NewsISRGIntuitive Surgical4.7968 of 5 stars$463.62+2.7%$611.86+32.0%+27.4%$165.13B$8.35B72.3312,100Upcoming EarningsPositive NewsHigh Trading Volume Remove Ads Related Companies and Tools Related Companies AtriCure Competitors Integra LifeSciences Competitors Alphatec Competitors Orthofix Medical Competitors AngioDynamics Competitors Accuray Competitors Rockwell Medical Competitors ReShape Lifesciences Competitors Abbott Laboratories Competitors Intuitive Surgical Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:SRDX) was last updated on 4/15/2025 by MarketBeat.com Staff From Our Partners[Action Required] Claim Your FREE IRS Loophole GuideThis shouldn't surprise anyone who's been paying attention, but... Pres. Trump may be about to unleash the ...Colonial Metals | SponsoredGet Your Bank Account “Fed Invasion” Ready with THESE 4 Simple StepsStarting as soon as a few months from now, the United States government will make a sweeping change to bank ac...Weiss Ratings | SponsoredThe Trump Dump is starting; Get out of stocks now?The first 365 days of the Trump presidency… Will be the best time to get rich in American history.Paradigm Press | SponsoredElon Musk Confirms: Tesla’s Optimus is Replacing Workers… and Heading to MarsElon Musk just confirmed Tesla’s robot will go to Mars. But on Earth, it may trigger a trillion-dollar tech sh...InvestorPlace | SponsoredAmerica’s Retirement Accounts Are at Risk—Here’s WhyWhen Trump took office in 2017, gold was just $1,100 an ounce. By the time he left, it had soared to $1,839. ...Premier Gold Co | SponsoredCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | SponsoredTrump to redistribute trillions of dollars Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to ...Porter & Company | SponsoredURGENT: This Altcoin Opportunity Won’t Wait – Act NowMy friends Joel and Adam have a simple motto: "For us, it's always a bull market." That’s because their 92%...Crypto Swap Profits | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Surmodics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Surmodics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy SRDX Stock Free SRDX Stock Alerts